Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases

M. Carmona-Abellan , R. Del Pino , A. Murueta-Goyena , M. Acera , B. Tijero , K. Berganzo , I. Gabilondo , J.C. Gómez-Esteban
{"title":"Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases","authors":"M. Carmona-Abellan ,&nbsp;R. Del Pino ,&nbsp;A. Murueta-Goyena ,&nbsp;M. Acera ,&nbsp;B. Tijero ,&nbsp;K. Berganzo ,&nbsp;I. Gabilondo ,&nbsp;J.C. Gómez-Esteban","doi":"10.1016/j.nrleng.2021.04.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objective</h3><p>Multiple system atrophy is a rare and fatal neurodegenerative disorder, characterized by autonomic dysfunction in association with either parkinsonism or cerebellar signs. The pathologic hallmark is the presence of alpha-synuclein aggregates in oligodendrocytes, forming glial cytoplasmic inclusions. Clinically, it may be difficult to distinguish form other parkinsonisms or ataxias, particularly in the early stages of the disease. In this case series we aim to describe in detail the features of MSA patients.</p></div><div><h3>Material and methods</h3><p>Unified MSA Rating Scale (UMSARS) score, structural and functional imaging and cardiovascular autonomic testing, are summarized since early stages of the disease.</p></div><div><h3>Results</h3><p>UMSARS proved to be useful to perform a follow-up being longitudinal examination essential to stratify risk of poor outcome. Neuropathological diagnosis showed an overlap between parkinsonian and cerebellar subtypes, with some peculiarities that could help to distinguish from other subtypes.</p></div><div><h3>Conclusion</h3><p>A better description of MSA features with standardized test confirmed by means of neuropathological studies could help to increase sensitivity.</p></div>","PeriodicalId":94155,"journal":{"name":"Neurologia","volume":"38 9","pages":"Pages 609-616"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2173580822001651/pdfft?md5=95562a937a1071eb8f03be54d906914e&pid=1-s2.0-S2173580822001651-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2173580822001651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective

Multiple system atrophy is a rare and fatal neurodegenerative disorder, characterized by autonomic dysfunction in association with either parkinsonism or cerebellar signs. The pathologic hallmark is the presence of alpha-synuclein aggregates in oligodendrocytes, forming glial cytoplasmic inclusions. Clinically, it may be difficult to distinguish form other parkinsonisms or ataxias, particularly in the early stages of the disease. In this case series we aim to describe in detail the features of MSA patients.

Material and methods

Unified MSA Rating Scale (UMSARS) score, structural and functional imaging and cardiovascular autonomic testing, are summarized since early stages of the disease.

Results

UMSARS proved to be useful to perform a follow-up being longitudinal examination essential to stratify risk of poor outcome. Neuropathological diagnosis showed an overlap between parkinsonian and cerebellar subtypes, with some peculiarities that could help to distinguish from other subtypes.

Conclusion

A better description of MSA features with standardized test confirmed by means of neuropathological studies could help to increase sensitivity.

多系统萎缩:一系列病例的临床、进化和组织病理学特征。
背景和目的:多系统萎缩是一种罕见且致命的神经退行性疾病,其特征是与帕金森病或小脑体征相关的自主神经功能障碍。病理特征是α -突触核蛋白聚集在少突胶质细胞中,形成胶质细胞质包涵体。临床上,它可能很难与其他帕金森病或共济失调症区分开来,特别是在疾病的早期阶段。在本病例系列中,我们旨在详细描述MSA患者的特征。材料和方法:从疾病早期开始,总结了统一MSA评定量表(UMSARS)评分、结构和功能成像以及心血管自主功能测试。结果:UMSARS被证明对进行随访是有用的,纵向检查对于分层不良结果的风险至关重要。神经病理学诊断显示帕金森和小脑亚型之间有重叠,有一些特点可以帮助与其他亚型区分开来。结论:通过神经病理学研究,通过标准化的测试来更好地描述MSA的特征,有助于提高敏感性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
53 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信